Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy

20 Aug 2025

Abstract excerpt

A rare T-cell lymphoma after chimeric antigen receptor (CAR) T-cell therapy for myeloma was linked to CCR4 overexpression and vector integration, which highlights the need for monitoring after CAR T-cell therapy.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Lymphoma Diagnosis and Treatment
Share to Viral Infectious Diseases and Gene Expression in Insects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40834307
DOI: 10.1056/nejmc2504588

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell TherapyPMID 40834307Read ↗

CAR-T Cell TherapySemantic proximity Read ↗

T-Cell Cancer after CAR T-Cell TherapySemantic proximity Read ↗

CAR T-cells profiling in carcinogenesis and tumorigenesis: An overview of CAR T-cells cancer therapySemantic proximity Read ↗

Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and ResistanceSemantic proximity Read ↗

The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell MalignancySemantic proximity Read ↗

Multiple Myeloma Cells Resistant to T-cell Therapies Exhibit a CD45+ Immunoevasive Phenotype.Semantic proximity Read ↗

Impact of clonal hematopoiesis on clinical outcomes to BCMA CAR-T in multiple myelomaSemantic proximity Read ↗

Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphomaSemantic proximity Read ↗

CAR T-Cell Therapy in Large B-Cell LymphomaSemantic proximity Read ↗

First-Ever CAR T-cell Therapy Approved in U.S.Semantic proximity Read ↗

Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell VectorSemantic proximity Read ↗

CAR T-Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds against Hematological MalignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.